- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Eloxx Pharmaceuticals Inc (ELOX)
Assess today's live Eloxx Pharmaceuticals Inc (ELOX) share price, performance and insights using our live OTC Markets: ELOX stock exchange data.
Analyse the historical data and Eloxx Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Eloxx Pharma share price buy/sell indicators using real-time data (or discuss the Eloxx Pharma (ELOX) stock price today with other investors in the Eloxx Pharma OTC share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OTC ELOX share price (ISIN: US29014R2022) to enhance your trading decisions with our free investment tools and resources.
What Is the Eloxx Pharmaceuticals Inc Share Price Today?
The Eloxx Pharma share price today is 0.100.
What Is the Stock Symbol for Eloxx Pharmaceuticals Inc
The stock symbol (or 'ticker') for Eloxx Pharmaceuticals Inc is "ELOX."
What Stock Exchange Does Eloxx Pharmaceuticals Inc Trade On?
Eloxx Pharmaceuticals Inc is listed and trades on the OTC Markets stock exchange.
Is Eloxx Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Eloxx Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Eloxx Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Eloxx Pharma share price buy/sell indicators using real-time data (or discuss the Eloxx Pharma (ELOX) stock price today with other investors in the Eloxx Pharma OTC share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OTC ELOX share price (ISIN: US29014R2022) to enhance your trading decisions with our free investment tools and resources.
What Is the Eloxx Pharmaceuticals Inc Share Price Today?
The Eloxx Pharma share price today is 0.100.
What Is the Stock Symbol for Eloxx Pharmaceuticals Inc
The stock symbol (or 'ticker') for Eloxx Pharmaceuticals Inc is "ELOX."
What Stock Exchange Does Eloxx Pharmaceuticals Inc Trade On?
Eloxx Pharmaceuticals Inc is listed and trades on the OTC Markets stock exchange.
Is Eloxx Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Eloxx Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
OTC Markets
Currency in USD
0.100
+0.100(+99,900.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.052
0.151
52 wk Range
0.040
0.151
Trading near 52-week High
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0520.151
52 wk Range
0.0400.151
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ELOX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readthrough of premature stop codons caused by nonsense mutations in the United States, Israel, and Australia. The company is developing exaluren, a eukaryotic ribosome-selective glycoside in a Phase 2 trial for the treatment of rare kidney diseases, including Alport syndrome with nonsense mutations, cystic fibrosis with nonsense mutations, and nephropathic cystinosis with nonsense mutations, as well as in a preclinical stage for the treatment of autosomal dominant polycystic kidney disease with nonsense mutations. It has collaboration with Almirall, S.A. to develop and commercialize ZKN-013, an oral ribosome modulating agent for the treatment of rare skin diseases, such as recessive dystrophic epidermolysis bullosa and junctional epidermolysis bullosa with nonsense mutations. Eloxx Pharmaceuticals, Inc. is based in Arlington, Massachusetts.
Compare ELOX to Peers and Sector
Metrics to compare | ELOX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipELOXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −0.3x | −0.5x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | - | 0.6x | 2.6x | |
Price / LTM Sales | - | 1.5x | 3.2x | |
Upside (Analyst Target) | - | 203.7% | 53.4% | |
Fair Value Upside | Unlock | 17.2% | 7.7% | Unlock |
Earnings
Latest Release
13/11/2023
EPS / Forecast
-1.31 / -1.97
Revenue / Forecast
-- / 900K
FAQ
What Is the Eloxx Pharma (ELOX) Share Price Today?
The Eloxx Pharma stock price today is 0.100 USD.
What Stock Exchange Does Eloxx Pharma (ELOX) Trade On?
Eloxx Pharma is listed and trades on the OTC Markets.
What Is the Ticker (Stock Symbol) for Eloxx Pharma?
The stock symbol (also called a 'ticker') for Eloxx Pharma is "ELOX."
What Is the Current Eloxx Pharma Market Cap?
As of today, Eloxx Pharma market cap is 330.050K USD.
What Is Eloxx Pharma's (ELOX) Earnings Per Share (TTM)?
The Eloxx Pharma EPS is currently -8.816 (Trailing Twelve Months).
Is ELOX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Eloxx Pharma moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Eloxx Pharma Stock Split?
Eloxx Pharma has split 3 times. (See the ELOX stock split history page for full effective split date and price information.)
How Many Employees Does Eloxx Pharma Have?
Eloxx Pharma has 18 employees.
What is the current trading status of Eloxx Pharma (ELOX)?
As of 19/03/2026, Eloxx Pharma (ELOX) is trading at a price of 0.100 USD, with a previous close of 0.000 USD. The stock has fluctuated within a day range of 0.052 USD to 0.151 USD, while its 52-week range spans from 0.040 USD to 0.151 USD.
What Is the ELOX Premarket Price?
ELOX's last pre-market stock price is 0.001 USD. The pre-market share volume is 20.000, and the stock has decreased by -0.039, or -97.500%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.